Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 4,000 shares at $40.00 ($160K) on 2021-06-17, disclosed to the SEC on 2021-06-21.
Open-market sale of $160k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |